From: Understanding Haemophilus parasuis infection in porcine spleen through a transcriptomics approach
Functional classification | Gene Discriptionb | GenBank ID | FCc | p-valued |
---|---|---|---|---|
Inflammatory response | Resistin | NM_020415 | 25.9 | 2.70E-02 |
 | S100 calcium binding protein A9 | NM_002965 | 21.8 | 1.60E-03 |
 | S100 calcium binding protein A12 | NM_005621 | 16.6 | 1.29E-02 |
 | S100 calcium binding protein A8 | NM_002964 | 8.4 | 2.29E-02 |
 | Chitinase 3-like 1 | NM_001276 | 6.3 | 1.45E-02 |
 | Calpain; small subunit 1 | NM_001003962 | 5.7 | 2.50E-03 |
 | Interleukin 1 receptor accessory protein | NM_002182 | 4.6 | 6.00E-04 |
 | Complement component 3 | NM_000064 | 3.3 | 4.51E-02 |
 | Solute carrier family 2, member 3 | NM_006931 | 3.3 | 4.05E-02 |
 | Interleukin 10 receptor; beta | NM_000628 | 2.8 | 3.47E-02 |
 | ADAM metallopeptidase with thrombospondin type 1 motif 1 | NM_006988 | 2.6 | 2.24E-02 |
 | Histone deacetylase 9 | NM_014707 | 0.5 | 7.00E-04 |
 | Chemokine (C-C motif) ligand 5 | NM_002985 | 0.4 | 3.30E-03 |
Acute-phase response | Serum amyloid A1 | NM_000331 | 23.9 | 1.35E-02 |
 | Lactotransferrin | NM_002343 | 13.0 | 2.26E-02 |
 | Angiotensinogen | NM_000029 | 10.2 | 6.50E-03 |
 | Haptoglobin | NM_005143 | 10.0 | 1.36E-02 |
 | Ceruloplasmin/ferroxidase | NM_000096 | 4.9 | 4.09E-05 |
Humoral immune response | CD163 antigen | NM_203416 | 4.6 | 3.56E-02 |
 | Extracellular matrix protein 1 | NM_004425 | 2.7 | 9.90E-03 |
 | Lysozyme | NM_000239 | 2.3 | 4.20E-03 |
 | CD2 (cytoplasmic tail) binding protein 2 | NM_006110 | 0.4 | 2.79E-02 |
Cell differentiation | Transglutaminase 1 | NM_000359 | 22.3 | 1.62E-02 |
 | Membrane-spanning 4-domains; subfamily A; member 8B | NM_031457 | 20.5 | 1.61E-02 |
 | Cystatin A | NM_005213 | 13.1 | 3.78E-02 |
 | Serpin peptidase inhibitor, clade E, member 2 | NM_006216 | 3.6 | 2.74E-02 |
 | Secreted frizzled-related protein 1 | NM_003012 | 2.3 | 3.23E-02 |
 | Growth arrest and DNA-damage-inducible; gamma | NM_006705 | 2.0 | 2.79E-02 |
 | Carnitine deficiency-associated; expressed in ventricle 1 | NM_014055 | 0.4 | 2.24E-02 |
 | Myeloid leukemia factor 1 | NM_022443 | 0.4 | 1.61E-02 |
 | Stathmin-like 2 | NM_007029 | 0.2 | 4.11E-02 |
 | Mal; T-cell differentiation protein | NM_022438 | 0.2 | 2.82E-02 |
Cell adhesion | Claudin 3 | NM_001306 | 9.7 | 2.34E-02 |
 | Chondroitin sulfate proteoglycan 2/versican | NM_004385 | 9.3 | 7.50E-03 |
 | Lectin, galactoside-binding, soluble, 8 | NM_006499 | 2.8 | 7.10E-03 |
 | CD44 antigen | NM_001001392 | 2.5 | 5.50E-03 |
 | Immunoglobulin superfamily containing leucine-rich repeat | NM_201526 | 2.3 | 3.44E-02 |
 | Discs; large homolog 5 | NM_004747 | 2.2 | 2.05E-02 |
 | Thrombospondin 1 | NM_003246 | 2.2 | 3.49E-02 |
 | Collagen; type XV; alpha 1 | NM_001855 | 2.0 | 1.03E-02 |
 | Nephronophthisis 1 | NM_000272 | 0.5 | 2.18E-02 |
 | Nuclear receptor subfamily 3; group C; member 2 | NM_000901 | 0.4 | 3.18E-02 |
 | Fibronectin leucine rich transmembrane protein 3 | NM_198391 | 0.4 | 3.62E-02 |
 | PDZ domain containing 2 | NM_178140 | 0.3 | 8.10E-03 |
Response to oxidative stress | Superoxide dismutase 2; mitochondrial | NM_000636 | 3.8 | 6.10E-03 |
 | Dual specificity phosphatase 1 | NM_004417 | 2.1 | 2.05E-02 |
Homeostasis | Transcobalamin I | NM_001062 | 17.7 | 3.06E-02 |
 | Solute carrier organic anion transporter family, member 2A1 | NM_005630 | 3.0 | 5.00E-04 |
 | ATP-binding cassette, sub-family A (ABC1), member 5 | NM_018672 | 2.6 | 2.48E-02 |
Transcription factor | Zinc finger and BTB domain-containing protein 16 | Q05516 | 5.6 | 9.20E-03 |
 | CCAAT/enhancer binding protein (C/EBP), delta | NM_005195 | 4.7 | 4.59E-02 |
 | Solute carrier family 39 (zinc transporter), member 14 | NM_015359 | 4.5 | 3.66E-02 |
 | CCAAT/enhancer binding protein (C/EBP), beta | NM_005194 | 3.1 | 3.00E-02 |
 | Nuclear factor; interleukin 3 regulated | NM_005384 | 2.3 | 4.70E-03 |
Response to wounding | Macrophage stimulating 1 | NM_020998 | 2.9 | 3.31E-02 |
 | Coagulation factor III | NM_001993 | 2.8 | 1.74E-02 |
 | Annexin A8 | NM_001630 | 2.4 | 4.19E-02 |
 | Coagulation factor XIII; A1 polypeptide | NM_000129 | 2.4 | 4.59E-02 |
Other responses to stimulus | GTP binding protein overexpressed in skeletal muscle | NM_181702 | 3.6 | 1.73E-02 |
 | Period homolog 1 | NM_002616 | 2.6 | 7.50E-03 |
 | Interleukin 4 receptor | NM_000418 | 2.2 | 2.57E-02 |
 | Major histocompatibility complex; class II; DR beta 1 | NM_002124 | 0.5 | 4.18E-02 |
 | Guanylate binding protein 1; interferon-inducible; 67 kDa | NM_002053 | 0.5 | 8.70E-03 |
 | DnaJ | NM_012266 | 0.5 | 3.60E-03 |
 | Pituitary tumor-transforming 1 | NM_004219 | 0.5 | 5.00E-04 |
 | Potassium voltage-gated channel; subfamily H | NM_172057 | 0.5 | 4.33E-02 |
 | Major histocompatibility complex; class I; B | NM_005514 | 0.3 | 6.00E-04 |
Development | Cofilin 1 | NM_005507 | 19.4 | 3.18E-02 |
 | P8 protein | NM_012385 | 5.4 | 1.57E-02 |
 | Neuron navigator 1 | NM_020443 | 3.4 | 1.92E-02 |
 | apolipoprotein D | NM_001647 | 2.6 | 8.00E-03 |
 | Protein tyrosine phosphatase; non-receptor type 1 | NM_002827 | 2.3 | 4.58E-02 |
 | Putative insulin-like growth factor II associated prote | NM_001007139 | 2.2 | 2.60E-03 |
 | FYVE; RhoGEF and PH domain containing 4 | NM_139241 | 2.2 | 4.74E-02 |
 | Slingshot homolog 2 | NM_033389 | 2.2 | 3.00E-04 |
 | 3-phosphoadenosine 5-phosphosulfate synthase 2 | NM_001015880 | 2.1 | 2.89E-02 |
 | Epimorphin | NM_194356 | 0.5 | 4.16E-02 |
 | Chondrolectin | NM_024944 | 0.5 | 2.66E-02 |
 | Ecotropic viral integration site 5 | NM_005665 | 0.5 | 1.52E-02 |
 | SMAD; mothers against DPP homolog 5 | NM_001001419 | 0.5 | 4.20E-02 |
 | Stearoyl-CoA desaturase | NM_005063 | 0.5 | 1.16E-02 |
 | Ankyrin 3, node of Ranvier | NM_001149 | 0.5 | 9.40E-03 |
 | Insulin-like growth factor 2 | NM_000612 | 0.4 | 1.76E-02 |
 | SRY | NM_003108 | 0.4 | 4.06E-02 |
 | Chromosome 11 open reading frame 8 | NM_001584 | 0.4 | 3.25E-02 |
 | Actin; alpha; cardiac muscle | NM_005159 | 0.3 | 8.10E-03 |
 | Cellular retinoic acid binding protein 1 | NM_004378 | 0.1 | 4.34E-02 |
 | Erythroid associated factor | NM_016633 | 0.01 | 6.70E-03 |
Urea cycle | Arginase; type II | NM_001172 | 2.1 | 1.41E-02 |
 | Arginase; type I | NM_000045 | 0.2 | 2.53E-02 |
Organismal physiological process | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F | NM_152878 | 5.2 | 2.00E-04 |
 | Uridine phosphorylase 1 | NM_181597 | 4.4 | 1.94E-02 |